Cargando…
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study
Background: CT lung extent has emerged as a potential risk factor of COVID-19 pneumonia severity with mainly semiquantitative assessment, and outcome was not assessed in the specific oncology setting. The main goal was to evaluate the prognostic role of quantitative assessment of the extent of lung...
Autores principales: | Ramtohul, Toulsie, Cabel, Luc, Paoletti, Xavier, Chiche, Laurent, Moreau, Pauline, Noret, Aurélien, Vuagnat, Perrine, Cherel, Pascal, Tardivon, Anne, Cottu, Paul, Bidard, François-Clément, Servois, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494966/ https://www.ncbi.nlm.nih.gov/pubmed/33014804 http://dx.doi.org/10.3389/fonc.2020.01560 |
Ejemplares similares
-
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
por: Vuagnat, Perrine, et al.
Publicado: (2020) -
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
por: Basse, Clémence, et al.
Publicado: (2021) -
Pretreatment Tumor Growth Rate and Radiological Response as Predictive Markers of Pathological Response and Survival in Patients with Resectable Lung Cancer Treated by Neoadjuvant Treatment
por: Ramtohul, Toulsie, et al.
Publicado: (2023) -
Première vague COVID-19 : expérience d’un centre de lutte contre le cancer
por: Frelaut, Maxime, et al.
Publicado: (2021) -
Does sacituzumab-govitecan act as a conventional antibody drug conjugate (ADC), a prodrug of SN-38 or both?
por: Santi, Daniel V., et al.
Publicado: (2021)